Current concepts in total femoral replacement

Table 2 Large case series of total femoral replacement in current literature

Ref.	Publication	n	Age	Indications	Follow-up (mo)	Patients living at time of publication	Survivorship	All-cause revision rate	Complications	Prosthesis used
Ahmed[28]	Arch Orthop Trauma Surg	9	47 (10-74)	Oncologic	51 (8-200)	4/9	No failures	0%	Infection (2), tibial component loosening (1)	Zimmer
Amanatullah et al[3]	J Arthroplasty	20	65 ± 11	Non-oncologic (revision arthroplasty)	73 ± 49	0/20	70% at 5 yr follow-up	30%	Infection (7), hip dislocation (5), limb length discrepancy (2), knee flexion contracture (1)	Biomet, Link Stryker
Berend et al[2]	Clin Orthop Relat Res	59	74 (39-91)	Non-oncologic (end-stage prosthetic disease)	58 (12-156)	14/59	65% at 5 yr follow-up	30.5%	Infection (8), hip dislocation (7), tibial component loosening (2), acetabular component loosening (1)	Biomet, Link
Fountain et al[10]	J Arthroplasty	14	63.7 (48-79)	Non-oncologic (revision arthroplasty)	90 (12-204)	13/14	NA	35.7%	Hip dislocation (5), infection (3)	Link
Friesecke et al[30]	J Bone Joint Surg Am	100	68 (40-94)	Non-oncologic (revision arthroplasty)	59 (1-138)	95/100	NA	21%	Infection (12), hip dislocation (6), prosthesis failure (3), patellar issues (2), hematoma (2), peroneal nerve palsy (1), delayed wound healing (1)	Link
Lombardi et al[12]	J Arthroplasty	75	73 (36-92)	Non-oncologic (end-stage prosthetic disease)	42 (1-158)	50/75	NA	30.7%	Infection (11), hip dislocation (7), tibial component loosening (2), acetabular component loosening (1), hematoma (1), periprosthetic fracture (1)	NA
Mankin et al[14]	Clin Orthop Relat Res	15	52 ± 1 (16-82)	Oncologic, non-oncologic (Paget’ s disease, rheumatoid arthritis)	54 (12-192)	7/15	NA	33.3%	Prosthesis failure (4), infection (1)	NA
Nerubay et al[26]	Clin Orthop Relat Res	19	20	Oncologic	18-96	7/19	NA	-	Wound healing problems (10), infection (1), popliteal vein injury (1), prosthesis failure (1)	NA
Steinbrink et al[33]	J Bone Joint Surg Br	32 (28 patients)	56 (21-81)	Oncologic, non-oncologic (end-stage prosthetic disease, revision arthroplasty, pathologic fractures, osteoporosis)	6-84	23/28	NA	9.4%	Infection (2), hip dislocation (1), prosthesis failure (1), patellar pain (1)	Custom
Ward et al[34]	Clin Orthop Relat Res	21	44.6 (11-91)	Oncologic, non-oncologic (revision arthroplasty, end-stage prosthetic disease)	31 (1-125)	11/21	NA	2.4%	Infection (3), hip dislocation (2), patellar pain (1)	Custom

NA: Information was not available in article.